Topic Archives: Myriad Genetics (MYGN)

Comments

  • Avatar

    When this wonderful Mampilly recommendation for MYGN was made MYGN was trading at, or around $49 - $50, it is now tradi...

  • Avatar

    mu is the AI stock. He also recommends amd and mygn...

  • Avatar

    STEVENSON, Md., April 23, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Co...

  • Avatar

    Huge drop (12+%) in MyGn today after a subpoena was issued from HHS over claims of improper or false billing to Medicare...

  • Avatar
  • Avatar

    Myriad Genetics - Travis has written about this before: https://www.stockgumshoe.com/reviews/profits-unlimited/greate...

  • Avatar

    NOT all PM's PU portfolio ar winners. But, he surely has some big gains on some of them. Here is the PM's performance pi...

  • Avatar

    Has Myriad Genetics (MYGN) ever been brought up on gumshoe? I can't recall, but I am recently browsing over the company...

  • Avatar

    Tnx Travis for such interesting comments and for hosting those of others. As an old-fashioned P&F chart follower, G...

  • Avatar

    A couple of months ago, Myriad genetics MYGN spun off it's pharma division as Myriad Pharmaceuticals MYRX. For a couple ...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch